ArticleLeukemia & lymphoma2021
Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists.
2 registry-linked trialsOpen access · greenAbstract read
In one paragraph
Article in Leukemia & lymphoma, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 26 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
A Pilot Randomized Controlled Trial of a Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
Who cites it
26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 31 citations in OpenAlex.
- Healthcare Professionals' Perceptions of Decision-Making for Older Patients with Cancer Receiving Systemic Therapy: A Systematic Review and Qualitative Evidence Synthesis.Annals of geriatric medicine and research · 2026Pooled it
- American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults.Blood advances · 2026Guideline
- A Systematic Review of Decision Aids in Hematologic Malignancies: What Are Currently Available and What Are We Missing?The oncologist · 2023Pooled it
- A single-arm pilot study of a mobile health exercise intervention (GO-EXCAP) in older patients with myeloid neoplasms.Blood advances · 2022Trial
- Caring for Older Adults with Acute Myeloid Leukemia: Best Practices for Aligning Patient Fitness and Preference with Available Therapies.Drugs & aging · 2026Review
- Factors Associated with Receipt of Allogeneic Hematopoietic Cell Transplant and NMDP Donor Search in Older Adults with Acute Myeloid Leukemia.Transplantation and cellular therapy · 2026Article
- Article
- Protocol of a decisional intervention for older adults with newly diagnosed acute myeloid leukemia and their caregivers: UR-GOAL 3.Journal of geriatric oncology · 2025Article
- Barriers to participation in clinical trials of rural older adult cancer survivors: A qualitative study.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2025Article
- Addressing Ageism With Geriatric Assessment in Clinical Practice and Research.JCO oncology practice · 2024Article
- Communication Strategies of Transplant Hematologists in High-Risk Decision-Making Conversations.JCO oncology practice · 2024Article
- Experiences of treatment decision-making among older newly diagnosed adults with acute myeloid leukemia: a qualitative descriptive study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- Geriatric Assessment in Acute Myeloid Leukemia.Acta haematologica · 2024Review
- Article
- Outcomes and survival predictors of Latin American older adults with acute myeloid leukemia: Data from a single center.Hematology, transfusion and cell therapy · 2023Article
- Patient preferences, regret, and health-related quality of life among older adults with acute myeloid leukemia: A pilot longitudinal study.Journal of geriatric oncology · 2023Article
- Patient-centered communication tool for older patients with acute myeloid leukemia, their caregivers, and oncologists: A single-arm pilot study.Cancer medicine · 2023Article
- Advance care planning in older patients with acute myeloid leukemia and myelodysplastic syndromes.Journal of geriatric oncology · 2023Article
- Adapting a patient-centered communication tool for older patients with acute myeloid leukemia and their oncologist.Blood advances · 2022Article
- Older patients' experiences following initial diagnosis of acute myeloid leukemia: A qualitative study.Journal of geriatric oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 8 institutions in 1 country.
Kah Poh LohJames P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-6978-0418
Maya AbdallahDepartment of Medicine, Sections of Geriatrics and Hematology/Oncology, Boston University School of Medicine, Boston, MA, USA.
Sindhuja KadambiJames P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Megan WellsJames P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Anita J KumarTufts Medical Center, Boston, MA, USA.
Jason H MendlerJames P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Jane L LiesveldJames P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Marsha WittinkDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA.
Kristen O'DwyerJames P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Michael W BeckerJames P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Colin McHughJames P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Wendy StockThe University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.
Navneet S MajhailBlood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Tanya M WildesDivision of Medical Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
Paul DubersteinRutgers School of Public Health, Piscataway, NJ, USA.
Supriya Gupta MohileJames P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Heidi D KlepinWake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.
University of Rochester Medical Center · USAtrium Health Wake Forest Baptist · USBoston University · USCleveland Clinic · USRutgers, The State University of New Jersey · USTufts Medical Center · USUniversity of Chicago · USWashington University in St. Louis · US
Funding
URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7MGeriatric Oncology Research Infrastructure to Improve Clinical CareR33AG059206 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WILLIAM DALE, Heidi Diana Klepin · 2020 to 2026
$5.1MA Patient-Oriented Research Program in Geriatric OncologyK24AG056589 · NIA · UNIVERSITY OF ROCHESTER · PI Supriya G. Mohile · 2018 to 2026
$1.5MA novel mobile health exercise intervention for older patients with myeloid neoplasmsR00CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2021 to 2023
$747kA Novel Mobile Health Exercise Intervention for Older Patients with Myeloid NeoplasmsK99CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2019 to 2020
$385kNCI NIH HHS K99 CA237744NCI NIH HHS R00 CA237744NCI NIH HHS UG1 CA189961NIA NIH HHS K24 AG056589NIA NIH HHS R33 AG059206
Abstract
Little is known about the characteristics of patients, physicians, and organizations that influence treatment decisions in older patients with AML. We conducted qualitative interviews with community oncologists and older patients with AML to elicit factors that influence their treatment decision-making. Recruitment was done
Indexed as
Leukemia, Myeloid, AcuteOncologistsAgedDecision MakingGeriatric AssessmentHumansQualitative Researchacute myeloid leukemiageriatric hematologyolder adultsTreatment decision-making
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
NCT05061095ClinicalTrials.gov
NCT05335369ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.